223 related articles for article (PubMed ID: 34253265)
1. Aspirin and omega-3 polyunsaturated fatty acid use and their interaction in cardiovascular diseases and colorectal adenomas.
Wang IE; Yi S; Block RC; Mousa SA
Nutr Res Rev; 2022 Dec; 35(2):295-307. PubMed ID: 34253265
[TBL] [Abstract][Full Text] [Related]
2. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function.
Welty FK; Daher R; Garelnabi M
Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):89-107. PubMed ID: 37916414
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
4. Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health.
Djuricic I; Calder PC
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():383-406. PubMed ID: 36662586
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and omega-3 fatty acid status interact in the prevention of cardiovascular diseases in Framingham Heart Study.
Block RC; Shearer GC; Holub A; Tu XM; Mousa S; Brenna JT; Harris WS; Tintle N
Prostaglandins Leukot Essent Fatty Acids; 2021 Jun; 169():102283. PubMed ID: 33964664
[TBL] [Abstract][Full Text] [Related]
6. Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials.
Huang L; Zhang F; Xu P; Zhou Y; Liu Y; Zhang H; Tan X; Ge X; Xu Y; Guo M; Long Y
Adv Nutr; 2023 Jul; 14(4):629-636. PubMed ID: 37121469
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products.
Fialkow J
Am J Cardiovasc Drugs; 2016 Aug; 16(4):229-239. PubMed ID: 27138439
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.
Yee LD; Lester JL; Cole RM; Richardson JR; Hsu JC; Li Y; Lehman A; Belury MA; Clinton SK
Am J Clin Nutr; 2010 May; 91(5):1185-94. PubMed ID: 20335550
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
Harris WS; Dayspring TD; Moran TJ
Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
[TBL] [Abstract][Full Text] [Related]
10. Variability in the Clinical Effects of the Omega-3 Polyunsaturated Fatty Acids DHA and EPA in Cardiovascular Disease-Possible Causes and Future Considerations.
Michaeloudes C; Christodoulides S; Christodoulou P; Kyriakou TC; Patrikios I; Stephanou A
Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004225
[TBL] [Abstract][Full Text] [Related]
11. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
12. Protective role of n6/n3 PUFA supplementation with varying DHA/EPA ratios against atherosclerosis in mice.
Liu L; Hu Q; Wu H; Xue Y; Cai L; Fang M; Liu Z; Yao P; Wu Y; Gong Z
J Nutr Biochem; 2016 Jun; 32():171-80. PubMed ID: 27142749
[TBL] [Abstract][Full Text] [Related]
13. n-3 fatty acids and cardiovascular disease.
Breslow JL
Am J Clin Nutr; 2006 Jun; 83(6 Suppl):1477S-1482S. PubMed ID: 16841857
[TBL] [Abstract][Full Text] [Related]
14. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.
Shoji T; Kakiya R; Hayashi T; Tsujimoto Y; Sonoda M; Shima H; Mori K; Fukumoto S; Tahara H; Shioi A; Tabata T; Emoto M; Nishizawa Y; Inaba M
Am J Kidney Dis; 2013 Sep; 62(3):568-76. PubMed ID: 23602192
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN(®) REVEAL Trial.
Shaikh NA; Yantha J; Shaikh S; Rowe W; Laidlaw M; Cockerline C; Ali A; Holub B; Jackowski G
Mol Cell Biochem; 2014 Nov; 396(1-2):9-22. PubMed ID: 25185754
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of long-chain n-3 polyunsaturated fatty acid supplementation on tuberculosis in mice.
Nienaber A; Ozturk M; Dolman RC; Zandberg L; Hayford FE; Brombacher F; Blaauw R; Smuts CM; Parihar SP; Malan L
Prostaglandins Leukot Essent Fatty Acids; 2021 Jul; 170():102304. PubMed ID: 34082319
[TBL] [Abstract][Full Text] [Related]
17. Association between dietary intake of omega-3 polyunsaturated fatty acids and all-cause and cardiovascular mortality among hypertensive adults: Results from NHANES 1999-2018.
Chen H; Leng X; Liu S; Zeng Z; Huang F; Huang R; Zou Y; Xu Y
Clin Nutr; 2023 Dec; 42(12):2434-2442. PubMed ID: 37871484
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality.
Jiang H; Wang L; Wang D; Yan N; Li C; Wu M; Wang F; Mi B; Chen F; Jia W; Liu X; Lv J; Liu Y; Lin J; Ma L
Clin Nutr; 2022 Aug; 41(8):1798-1807. PubMed ID: 35830775
[TBL] [Abstract][Full Text] [Related]
19. Effect of dietary EPA and DHA on murine blood and liver fatty acid profile and liver oxylipin pattern depending on high and low dietary n6-PUFA.
Kutzner L; Esselun C; Franke N; Schoenfeld K; Eckert GP; Schebb NH
Food Funct; 2020 Oct; 11(10):9177-9191. PubMed ID: 33030169
[TBL] [Abstract][Full Text] [Related]
20. The Pattern of Fatty Acids Displaced by EPA and DHA Following 12 Months Supplementation Varies between Blood Cell and Plasma Fractions.
Walker CG; West AL; Browning LM; Madden J; Gambell JM; Jebb SA; Calder PC
Nutrients; 2015 Aug; 7(8):6281-93. PubMed ID: 26247960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
